FemTech Startups
619 companies tagged FemTech, with their investors and founders.
J3 Bioscience develops LivRing, a patented intravaginal ring platform for sustained, controlled release of active and functional ingredients, licensed exclusively and globally from the University of Utah. The system targets women's health with localized or systemic delivery as an alternative to oral dosage forms for direct-to-consumer indications.
0 investors
Luna Genetics is a clinical genetics company offering prenatal and pre-conception genetic testing and diagnosis, supported by genetic counseling services. It operates a clinical laboratory focused on reproductive and prenatal genetics.
0 investors
Mamaya Health provides women's mental health care matched to specific life stages, including perinatal, postpartum, fertility, perimenopause/menopause, and cancer-related support, offering therapy, coaching, and psychiatric medication providers alongside structured programs. It partners with hospitals, OB-GYN practices, and specialty health networks to embed women's mental health care into medical systems, with a care-navigator matching model and most major insurances accepted.</parameter> <parameter name="founders">[]
0 investors
NannoCare makes NannoPad, organic cotton sanitary pads that use its Nannogenic far-infrared technology to help relieve menstrual cramps and discomfort. The direct-to-consumer products target women seeking natural period care and menstrual pain relief.
0 investors
O Positiv makes science-backed supplements for women's hormonal and vaginal health, including PMS gummy vitamins (FLO), menopause relief gummies (MENO), and a vaginal probiotic (URO). The direct-to-consumer brand focuses on women's health needs across life stages, from menstruation to menopause.
0 investors
Obstetrx develops a uterine tamponade medical device to control postpartum hemorrhage, adapting hemorrhage-control technology originally created for battlefield trauma. The company is working toward regulatory clearance and commercialization of the device in the US and globally, addressing women's health.
0 investors
Organic Conceptions offers a membership-based program with a personalized education path, a class library, live online events, community interaction, and private coaching aimed at supporting emotional wellness.
0 investors
Project Stardust develops consumer wearables for continuous fetal monitoring during pregnancy, aiming to detect conditions like fetal growth restriction earlier than periodic prenatal visits. The product targets expectant parents as an alternative to manual kick counting and infrequent ultrasounds.
0 investors
PROMISS Diagnostics develops diagnostic tools that apply analytics to common blood tests to expand their diagnostic capability. The company focuses on affordable, accessible medical diagnostics in the healthcare and life sciences space.
0 investors
Ravgen develops noninvasive prenatal genetic testing, using DNA-based methods to detect fetal genetic conditions such as Down's syndrome from a maternal blood sample. It serves pregnant patients seeking prenatal diagnostic information without the miscarriage risk of invasive procedures.
0 investors
Serenity Medical is a medical device company developing the River Stent, an investigational device for treating debilitating venous diseases such as Idiopathic Intracranial Hypertension (IIH) and Pulsatile Tinnitus, conditions that disproportionately affect women.
0 investors
Sermonix Pharmaceuticals is a privately held biotechnology company developing female-specific oncology products, with a lead investigational drug, lasofoxifene, being studied for breast and ovarian cancer. Its ELAINE study evaluates lasofoxifene versus fulvestrant in women with ER+/HER2- metastatic breast cancer carrying an ESR1 mutation.
0 investors
Spring Fertility operates fertility clinics offering treatments including in vitro fertilization (IVF), IUI, egg freezing, and embryo cryopreservation for individuals and couples building or preserving their fertility. It runs clinics across California, New York, Oregon, and Colorado.
0 investors
Vaginal Biome Science (VBS) is a biotechnology and R&D company developing microbiome-based diagnostics, therapeutics, and consumer care products for vaginal health, using its patented BioMatch technology and clinical research such as the VENUS Study. It serves the women's health market with clinically validated products and microbiome measurement tools.
0 investors
Vesiflo makes the inFlow device for emptying the bladder and is developing the Guardian Program, a remote monitoring and clinical information system for community-dwelling women with chronic urinary retention. The system automatically transmits urine-output data via an app to the cloud and can alert clinicians or caregivers when output is low.
0 investors
Walela develops a fetal sensor that provides objective data on a baby's health during labor, helping obstetricians decide whether a C-section is necessary with greater confidence and less liability. The company targets healthcare institutions and clinicians in the prenatal and childbirth monitoring space.
0 investors
Wave Bye develops non-prescription medications and supplements formulated to reduce period pain, bleeding, and cycle irregularity in women. Its product line includes OBGYN-formulated supplements and an FDA-approved medication for period cramps, sold directly to consumers.
0 investors
Women's Elite Rugby (WER) is the first professional women's rugby league in the United States, launched in 2024 with six founding teams across Boston, Chicago, Denver, New York, Northern California, and the Twin Cities. It organizes elite competition, sells tickets and merchandise, and streams matches live, building on the legacy of the Women's Premier League.
0 investors
Yinova Center is an acupuncture and wellness clinic offering acupuncture, Chinese herbal medicine, massage, and fertility support through personalized treatments including consultations, custom herbal formulas, and nutrition plans. It serves patients via in-clinic and virtual appointments, with locations in Manhattan and Brooklyn, New York City.
0 investors